ArticleTranslational oncology2025

MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy.

Gaofeng Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.